come sempre cerco di tenervi il più aggiornati possibile riguardo l'intercytex.
ha espanso il management interno.....
Intercytex expands Executive Management team"
Cambridge, UK, 6 September 2005 - Intercytex, the cell therapy company developing products for the advanced woundcare and aesthetic medicine markets, today announces the appointment of John St Clair Roberts MRCS, LRCP, FFPM, as Vice President Medical Affairs.
Dr St Clair Roberts has over 20 years of experience in the clinical development of vaccines and biological products. Previously he held the position of Medical Director at a number of leading biotechnology companies including Microscience plc, Xenova Group plc, Cantab Pharmaceuticals plc and Merieux UK.
He graduated in medicine from the Royal College of Surgeons in Ireland and, prior to his career in industry, he practised hospital medicine for a number of years in the National Health Service (UK). He has contributed to numerous publications, presentations, technical committees and lectures and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians and the Royal Society of Medicine.
“I am delighted to welcome John to Intercytex,” said Nick Higgins, Intercytex’ Chief Executive Officer. “He brings a wealth of clinical, regulatory and medical expertise to the Company, which will be invaluable to Intercytex at this stage of its corporate and product development.”
saluti